XML 37 R20.htm IDEA: XBRL DOCUMENT
v3.24.1

EARNINGS PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2023
EARNINGS PER SHARE |
EARNINGS PER SHARE | 14. EARNINGS PER SHARE The following represents the calculation of earnings (loss) per share (in thousands, except per share amounts):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Years Ended December 31,
​ |  | 2023 |  | 2022
Basic: | ​ | ​ | ​ | ​ | ​ | ​
Net (loss) income | ​ | $ | (3,048) | ​ | $ | 18,539
Less: Preferred stock dividend | ​ | ​ | (12,047) | ​ | ​ | —
Less: Undistributed earnings allocable to preferred stockholders | ​ | ​ | — | ​ | ​ | —
Net (loss) income available to common stockholders | ​ | $ | (15,095) | ​ | $ | 18,539
Weighted average basic number of common shares outstanding basic | ​ | ​ | 16,441 | ​ | ​ | 16,331
Basic net (loss) income per share of common stock | ​ | $ | (0.92) | ​ | $ | 1.14
​ | ​ | ​ | ​ | ​ | ​ | ​
Diluted: | ​ | ​ | ​ | ​ | ​ | ​
Net (loss) income available to common stockholders basic | ​ | $ | (15,095) | ​ | $ | 18,539
Reallocation of undistributed earnings | ​ | ​ | — | ​ | ​ | —
Net (loss) income available to common stockholders diluted | ​ | $ | (15,095) | ​ | $ | 18,539
Weighted average basic number of common shares outstanding | ​ | ​ | 16,441 | ​ | ​ | 16,331
Common stock equivalent shares representing shares issuable upon: | ​ | ​ | ​ | ​ | ​ | ​
Exercise of warrants and stock options | ​ | ​ | Anti-dilutive | ​ | ​ | Anti-dilutive
Vesting of restricted stock units | ​ | ​ | Anti-dilutive | ​ | ​ | 179
Weighted average diluted number of common shares outstanding diluted | ​ | ​ | 16,441 | ​ | ​ | 16,510
Diluted net income (loss) per share of common stock | ​ | $ | (0.92) | ​ | $ | 1.12
​ For the year ended December 31, 2023, common stock equivalents, including stock options and certain restricted stock units, totaling 0.5 million weighted-average shares were anti-dilutive and not included in the computation of diluted earnings per share of common stock. For the year ended December 31, 2022, common stock equivalents, including warrants, stock options and restricted stock units, totaling 5.8 million shares were not included in the computation of diluted earnings per share of common stock because the effect would have been anti-dilutive due to the Company’s net loss in the period. Additionally, the Company also has approximately 0.1 million restricted stock units that vest only upon achievement of certain business combination goals or based on the Company’s TSR as further described in Note 12, “Stockholder’s Equity”. On October 8, 2022 approximately 6.9 million warrants expired which previously gave the holder the right to purchase one share of common stock for each warrant.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration